Calendar

Cloudflare has a confirmed Nov 5 date and strong expected revenue growth, but checked sources did not establish a positive EPS revision/ESP or revenue upside beyond consensus. The stock's retrieved tape weakened sharply Oct 28–29 after an earlier surge; no qualifying close-location or 1.5x accumulation signal was verified, leaving no reliable pre-event surprise setup.

Airbnb's latest filed quarter showed strong revenue and booking growth, but the share price weakened into the event and checked sources did not establish a positive Q3 EPS revision/ESP or revenue upside versus consensus. The essential surprise and tape signals are missing or negative.

EOG has a solid upward EPS-revision trend and strong recent price appreciation, with a high close location on Oct. 29, but no checked source established positive revenue revisions and no recent session in the last three showed volume above 1.5x normal. The available evidence does not meet the required volume/revenue setup tests.

Three-month upward revisions to Q1 FY2027 EPS and revenue, alongside Lumentum’s stated demand momentum and backlog, are constructive; however, the latest available session closed in the lower part of its range and checked data do not establish the required strong close, 1.5x volume accumulation, sector tape, or adequate red-flag clearance.

SPG is scheduled to report after the close November 5, and its recent price strength includes an October 29 close near the top of that day’s range. However, the prior quarter missed EPS consensus, current checked sources show no positive EPS revision or revenue-upside indicator, and recent volumes were below a 1.5x-normal confirmation level.

Zacks reported a positive 11.64% 30-day EPS consensus revision and estimates of $1.24 EPS and $7.33B revenue, but no checked source established a positive revenue revision or required pre-event close-location and volume signals; this is insufficient for a qualifying setup.

TEAM has a confirmed Nov. 5 report date, consensus revenue near $1.71B, and a history of frequent EPS beats, but the latest tape showed a sharp high-volume decline into the event while software-sector tape was weak; the checked sources did not verify a positive EPS revision/ESP or revenue upside indicator.

MCHP has a verified Q2 FY27 call date, a recent upward EPS consensus revision, and a sharp October 27 rebound with a strong close; however, available sources do not establish a positive revenue revision, recent volume does not clearly exceed 1.5x normal on an up day, and the tape and sector-relative picture remain incomplete. The evidence is insufficient for a qualifying pre-event setup.

EPS estimate revisions improved materially, and the utility sector was not collapsing, but no positive revenue revision/upside signal was verified; recent sessions also lacked the required strong close and 1.5x volume confirmation. This is not a qualifying pre-earnings surprise setup.

Live Nation's official Oct. 22 announcement and IR calendar place its Q3 2026 earnings release after market on Nov. 5, outside the requested Nov. 4 window and contrary to the supplied Oct. 29 date. The date conflict means it does not qualify for this screen; the official release also provides a credible report date.

Arm's latest company guidance and prior-quarter disclosures support AI-related demand and a revenue-growth case, while Yahoo Finance showed net positive recent EPS revisions; however, price/volume checks do not confirm accumulation, the recent semiconductor tape had a down session, and the official earnings date differs from the supplied date. The evidence does not support a qualifying surprise setup.

Mixed-to-negative immediately after earnings: trusted [AP coverage](https://apnews.com/article/a2edaf9ec297fb75ff2a4e245063ec08) reports a 3.1% October 13 share decline tied to weaker-than-expected revenue despite a profit beat. The October 15 RankAlpha anchor is $82.75, but the packet does not establish whether the initial reaction fully held or reversed. Post-print target cuts are available, though a comprehensive forward-estimate revision series is not. The pre-print $1.85 EPS and $22.15 billion revenue estimates come from a third-party article stored as an earnings document, not an official company release. Social, options, short-interest and employee metrics are unavailable; zero values above are placeholders, not measured readings.

The SEC-filed earnings release confirms stronger Q2 adjusted results and raised guidance, but the market response was mixed: AZZ gained 0.7% on October 14, then fell 5.1% on October 15 to the $130.59 anchor. Four reported post-print analyst target changes include one cut and three increases; broader forward earnings-estimate revisions remain unavailable. The zero-valued social, options, short-interest, employee and news-sentiment fields denote unavailable measurements, not neutral readings. The deterministic prior shifted from positive to neutral, so this T+3 update remains a monitoring view. [#SEC-8K-2026-10-13] [Historical prices](https://chartexchange.com/symbol/nyse-azz/historical/) [Benzinga](https://www.benzinga.com/news/26/10/62385651/azz-analysts-boost-their-forecasts-after-upbeat-q2-results)

The initial October 13 close was $377.76, down 0.2% on the day; shares then closed at $395.62 on October 14 and $406.67 on October 15, about 7.4% above the pre-release October 12 close. The rebound occurred alongside broader healthcare buying, so it should not be attributed solely to earnings. Post-print target revisions were mixed, and a dependable aggregate estimate-revision series is unavailable. Social, options, short-interest and employee readings were not supplied; zero sentiment fields denote unavailable data, not neutral readings. https://chartexchange.com/symbol/nyse-unh/historical/ https://www.benzinga.com/quote/UNH/price-targets

The official earnings release was October 6, although the scheduled follow-up names October 13. Shares fell about 3.8% on October 6, from $45.46 to $43.72, then recovered only partly to the packet's $44.32 October 15 adjusted-close anchor; price action alone does not establish why investors sold. [Historical prices](https://chartexchange.com/symbol/nasdaq-vlgea/historical/) Verified post-print analyst revisions and consensus estimates remain unavailable, so missing coverage is not a positive signal. The prior neutral thesis remains broadly intact, but the Q4 cost pressure and fiscal 2027 investment plan sharpen monitoring priorities.

Company-reported results are positive, but the tape is mixed: Goldman rose more than 4% early on October 13, then closed about 0.2% lower, according to [AP](https://apnews.com/article/a2edaf9ec297fb75ff2a4e245063ec08). [Benzinga](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62363583/these-analysts-lower-their-forecasts-on-goldman-sachs-after-q3-results) reported RBC and KBW target cuts on October 14. The 30-day news score is a qualitative estimate; zero social, options, short-interest and employee fields denote unavailable measurements, not neutral readings. No verified broad estimate-revision series or company Q4 numerical guidance is available in the checked evidence.

Mixed post-earnings tone: JNJ fell 5.7% on October 13 despite reported beats and a modest guidance lift, then gained 1.6% on October 14; the October 15 anchor was $253.28. Several post-print price targets were cut, although at least one was raised. The October 15 close remained below the pre-print level, so the initial negative reaction had not fully reversed. No reliable social, options-skew, short-interest or employee-sentiment measures were supplied; the zero placeholders above mean unavailable, not neutral readings. [Market reaction](https://www.kiplinger.com/investing/stocks/stocks-struggle-ahead-of-september-cpi-report-stock-market-today) [Benzinga revisions](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62363208/these-analysts-cut-their-forecasts-on-johnson-and-johnson-after-q3-results) [October 15 close](https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/)